These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 7781071)
21. Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice. Gould KA; Dietrich WF; Borenstein N; Lander ES; Dove WF Genetics; 1996 Dec; 144(4):1769-76. PubMed ID: 8978062 [TBL] [Abstract][Full Text] [Related]
22. Loss of Apc+ in intestinal adenomas from Min mice. Luongo C; Moser AR; Gledhill S; Dove WF Cancer Res; 1994 Nov; 54(22):5947-52. PubMed ID: 7954427 [TBL] [Abstract][Full Text] [Related]
23. Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP. Nimmrich I; Friedl W; Kruse R; Pietsch S; Hentsch S; Deuter R; Winde G; Müller O Hum Genet; 1997 Sep; 100(3-4):345-9. PubMed ID: 9272153 [TBL] [Abstract][Full Text] [Related]
24. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice. Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247 [TBL] [Abstract][Full Text] [Related]
25. Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to Apc Min/+ tumorigenesis. Markova M; Koratkar RA; Silverman KA; Sollars VE; MacPhee-Pellini M; Walters R; Palazzo JP; Buchberg AM; Siracusa LD; Farber SA Oncogene; 2005 Sep; 24(42):6450-8. PubMed ID: 16007193 [TBL] [Abstract][Full Text] [Related]
26. Emergent issues in the genetics of intestinal neoplasia. Dove WF; Gould KA; Luongo C; Moser AR; Shoemaker AR Cancer Surv; 1995; 25():335-55. PubMed ID: 8718526 [TBL] [Abstract][Full Text] [Related]
27. Identification of Mom7, a novel modifier of Apc(Min/+) on mouse chromosome 18. Kwong LN; Shedlovsky A; Biehl BS; Clipson L; Pasch CA; Dove WF Genetics; 2007 Jun; 176(2):1237-44. PubMed ID: 17435219 [TBL] [Abstract][Full Text] [Related]
28. Three secretory phospholipase A(2) genes that map to human chromosome 1P35-36 are not mutated in individuals with attenuated adenomatous polyposis coli. Spirio LN; Kutchera W; Winstead MV; Pearson B; Kaplan C; Robertson M; Lawrence E; Burt RW; Tischfield JA; Leppert MF; Prescott SM; White R Cancer Res; 1996 Mar; 56(5):955-8. PubMed ID: 8640784 [TBL] [Abstract][Full Text] [Related]
29. Genetic analysis of intestinal polyp development in Collaborative Cross mice carrying the Apc (Min/+) mutation. Dorman A; Baer D; Tomlinson I; Mott R; Iraqi FA BMC Genet; 2016 Feb; 17():46. PubMed ID: 26896154 [TBL] [Abstract][Full Text] [Related]
30. Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms. Amos-Landgraf JM; Irving AA; Hartman C; Hunter A; Laube B; Chen X; Clipson L; Newton MA; Dove WF Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2060-5. PubMed ID: 22308460 [TBL] [Abstract][Full Text] [Related]
31. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Moser AR; Luongo C; Gould KA; McNeley MK; Shoemaker AR; Dove WF Eur J Cancer; 1995; 31A(7-8):1061-4. PubMed ID: 7576992 [TBL] [Abstract][Full Text] [Related]
32. Genetic mapping of Mom5, a novel modifier of Apc(Min)-induced intestinal tumorigenesis. Oikarinen SI; Cleveland AG; Cork KM; Bynoté KK; Rafter JJ; Gustafsson JA; Mutanen M; Gould KA Carcinogenesis; 2009 Sep; 30(9):1591-6. PubMed ID: 19574546 [TBL] [Abstract][Full Text] [Related]
33. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Dietrich WF; Lander ES; Smith JS; Moser AR; Gould KA; Luongo C; Borenstein N; Dove W Cell; 1993 Nov; 75(4):631-9. PubMed ID: 8242739 [TBL] [Abstract][Full Text] [Related]
34. Secretory phospholipase A2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis. Dobbie Z; Müller H; Scott RJ Hum Genet; 1996 Sep; 98(3):386-90. PubMed ID: 8707313 [TBL] [Abstract][Full Text] [Related]
35. A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice. Shoemaker AR; Moser AR; Midgley CA; Clipson L; Newton MA; Dove WF Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10826-31. PubMed ID: 9724789 [TBL] [Abstract][Full Text] [Related]
36. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Fodde R; Edelmann W; Yang K; van Leeuwen C; Carlson C; Renault B; Breukel C; Alt E; Lipkin M; Khan PM Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8969-73. PubMed ID: 8090754 [TBL] [Abstract][Full Text] [Related]
37. Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa. Praml C; Amler LC; Dihlmann S; Finke LH; Schlag P; Schwab M Oncogene; 1998 Oct; 17(15):2009-12. PubMed ID: 9788445 [TBL] [Abstract][Full Text] [Related]
38. Quantitation of in vivo gene delivery by restriction enzyme PCR generated polymorphism. Fichera A; Guo Y; Romero L; Michelassi F; Arenas RB J Surg Res; 1997 Apr; 69(1):188-92. PubMed ID: 9202668 [TBL] [Abstract][Full Text] [Related]
39. Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc(+) allele. Andreassen A ; Vikse R; Steffensen IL; Paulsen JE; Alexander J Mutagenesis; 2001 Jul; 16(4):309-15. PubMed ID: 11420398 [TBL] [Abstract][Full Text] [Related]